Assessing self-efficacy and well-being in patients with fibrotic interstitial lung disease
Official title: Self-efficacy and Well-being of Patients With Fibrotic Interstitial Lung Disease - an Observational Study
Run by Berner Reha Zentrum AG · NCT06027333 · Data updated 2026-11-12
This study is trying to see how patients with fibrotic interstitial lung disease feel about their quality of life and confidence in managing their health before and after rehabilitation or outpatient care.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 80 (estimated) |
| Sponsor | Berner Reha Zentrum AG Academic / other |
| Locations | 2 sites (Bern, Canton of Bern and 1 other locations) |
| Status | Recruiting |
| Started | November 8, 2023 |
| Main results expected | August 30, 2027 |
| Study ends | August 30, 2028 |
| Registry record updated | September 8, 2026 |
| Trial ID | NCT06027333 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults aged 18 and older diagnosed with fibrotic interstitial lung disease who are participating in rehabilitation or outpatient care.
✕Probably not a fit
Patients with cognitive impairments or those who do not speak German may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study invites patients with fibrotic interstitial lung disease (ILD) who are undergoing inpatient rehabilitation or outpatient pulmonary care to participate. Participants will complete questionnaires regarding their quality of life and symptoms at the beginning and end of their rehabilitation or after their second outpatient consultation. The study aims to evaluate changes in self-efficacy and quality of life over time, while also establishing a control cohort for a future feasibility study focused on educational and self-management interventions. Clinical data from routine care and the IIP registry will also be utilized.
Why it matters
Potential benefit: If successful, this study could enhance the understanding of self-efficacy and quality of life in patients with fibrotic ILD, leading to improved patient education and self-management strategies.
How similar studies have gone: While this study is observational and aims to establish a control cohort for future interventions, similar studies have shown promise in improving patient outcomes through self-management and education.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion criteria are: * For Berner Reha Zentrum only: Diagnosis of a FILD as major indication for pulmonary rehabilitation * For Inselspital only: Enrolled in Idiopathic interstitial Pneumonia (IIP) cohort study (Nr. 246/15 / PB\_2016-01524) and agreed to further use of data for further research purpose * Age ≥ 18 years * Written informed consent Exclusion criteria are: * Cognitive inability or insufficient knowledge of project language (German) to follow informed consent or study procedures * Sarcoidosis
Where it's running
-
Department of Pulmonary Medicine, Inselspital, Bern University Hospital, University of Bern
Bern, Canton of Bern, Switzerland Recruiting -
Berner Reha Zentrum, Rehabilitation & Sports Medicine, Insel Group, University Hospital Berne
Bern, Heiligenschwendi, Switzerland Recruiting
Study contacts
- Study coordinator: Thimo Marcin, PhD
- Email: t.marcin@rehabern.ch
- Phone: +41 33 244 30 48
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Stoma education and its effects on patients
This tests whether a teach-back stoma education program helps adults with a new colostomy or ileostomy feel more confident and manage their stoma better.
-
SELF-BREATHE: a self-guided online program to reduce chronic breathlessness in adults
This study will test whether SELF-BREATHE, a self-guided internet-based support program, can help adults with chronic breathlessness from lung or heart conditions breathe easier and feel less distressed.
-
Digital storytelling-based psychoeducation to ease loneliness and boost self-efficacy in adults aged 65–74
The study tests whether a digital storytelling–based psychoeducation program can reduce loneliness and improve self-efficacy in adults 65 to 74 who participate in the program versus a comparison group.
-
Sleep Better, Live Better: a 12-week coaching program to help adults improve sleep and heart-brain health
This trial tests a 12-week, telephone- and text-based sleep coaching program for adults 25–65 with short sleep and higher cardiometabolic risk to see if it improves sleep and related behaviors.
-
Telitacicept for primary Sjögren’s with interstitial lung disease
This study tests whether Telitacicept helps people with primary Sjögren’s syndrome and interstitial lung disease compared with standard immunosuppressants.
-
Inhaled mosliciguat for pulmonary hypertension in interstitial lung disease (PH-ILD) patients
This study tests inhaled mosliciguat versus placebo in people with PH-ILD to see if it helps with their condition.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.